The Nutshell

» funding, cancer and NIH

Daily News Roundup

Most Recent

image: Henrietta Lacks’s Family Seeks Compensation

Henrietta Lacks’s Family Seeks Compensation

By | February 16, 2017

Family members of Lacks, the donor behind the widely used HeLa cell line, are planning to sue Johns Hopkins University.

0 Comments

image: Tom Price Confirmed as HHS Director

Tom Price Confirmed as HHS Director

By | February 10, 2017

The orthopedic surgeon is confirmed to lead the US Department of Health and Human Services.

2 Comments

image: Trump Asks Collins to Stay On at NIH

Trump Asks Collins to Stay On at NIH

By | January 20, 2017

The president-elect asks Collins to remain director of the NIH through the transition. Whether Donald Trump will formally appoint Francis Collins has yet to be seen.

0 Comments

The US House of Representatives “Select Investigative Panel” recommends that the NIH investigate fetal tissue research, and consider no longer funding certain types. 

1 Comment

The tumor biologist’s landmark discovery provided the first clear evidence that genetic mutations could lead to cancer, and gave rise to a crucial cancer drug.

0 Comments

image: NIH: Allergen-Exposure Strategy Can Prevent Peanut Allergy

NIH: Allergen-Exposure Strategy Can Prevent Peanut Allergy

By | January 5, 2017

In light of recent allergen-exposure studies, an agency-sponsored panel has formally recommended early introduction of peanuts in an effort to prevent potentially life-threatening allergies.

0 Comments

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: Mouse Immunology Paper Retracted

Mouse Immunology Paper Retracted

By | December 16, 2016

A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.

1 Comment

image: MD Anderson Cancer Center’s Losses Grow

MD Anderson Cancer Center’s Losses Grow

By | December 13, 2016

The first two months of the fiscal year saw $102.4 million in operating losses.

1 Comment

In a pair of clinical studies of psilocybin, the active ingredient in magic mushrooms, participants reported positive changes to their moods and outlooks.

1 Comment

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Cannibalism: Not That Weird
    Reading Frames Cannibalism: Not That Weird

    Eating members of your own species might turn the stomach of the average human, but some animal species make a habit of dining on their own.

  4. Can Plants Learn to Associate Stimuli with Reward?
Business Birmingham